BeOne Medicines (BEIGF) Stock Price, News & Analysis
What Changed
Price Move History
- Daily moves over 5%
- 1 6 sessions, November 6, 2025 to June 9, 2026
- Largest daily move
- -5.2% close of April 9, 2026
Company Description
BeOne Medicines (OTC: BEIGF) is classified in the biotechnology industry within the Healthcare sector.
For FY2025, BeOne Medicines reported revenue of $5.3B with net income of $286.9M and diluted earnings per share of $0.19. The company operates at a net profit margin of 5.4%.
This page collects what Stock Titan holds for BEIGF, including price data, SEC filings, insider trading activity, financial highlights, and short interest trends.
Stock Performance
BeOne Medicines (BEIGF) closed at $21.95 on June 9, 2026.
BEIGF Metrics & Rankings
Price returns through June 9, 2026. Ranking links may use different dates.
Latest News
SEC Filings
BeOne Medicines has filed 10 recent SEC filings, including 6 Form 4, 3 Form 144, 1 Form SCHEDULE 13D/A. The most recent filing was submitted on . SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all BEIGF SEC filings →
Insider Radar
Insider selling at BeOne Medicines over the past 90 days can reflect routine portfolio management, scheduled trading plans (Rule 10b5-1), tax planning, or compensation-related dispositions rather than a directional view on the stock.
Financial Highlights
BeOne Medicines generated $5.3B in revenue in FY2025, retaining a 87.5% gross margin, operating income reached $447.1M (8.4% operating margin), and net income was $286.9M, reflecting a 5.4% net profit margin. Diluted earnings per share stood at $0.19. The company generated $1.1B in operating cash flow. The current ratio was 3.41, measuring current assets divided by current liabilities.
Upcoming Events
Short Interest History
Short interest in BeOne Medicines (BEIGF) currently stands at 90.8 thousand shares, down 44.3% from the previous reporting period, representing 0.0% of the float. Since November 2025, short interest has decreased by 88.5%.
Days to Cover History
Days to cover for BeOne Medicines (BEIGF) currently stands at 3.8 days, up 81.1% from the previous period. The ratio is the reported short interest divided by the average daily trading volume. Since November 2025, the figure has decreased by 89.9%. Across the settlements charted above, it has ranged from 1.0 to 1000.0 days.
BEIGF Company Profile & Sector Positioning
BeOne Medicines (BEIGF) operates in the Biotechnology industry within the broader Healthcare sector and is listed on the OTC.
Investors comparing BEIGF often look at related companies in the same sector, including CSL Ltd (CSLLY), CSL Ltd (CMXHF), UCB SA NPV (UCBJF), UCB SA (UCBJY), and Genmab A/S DKK (GNMSF). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate BEIGF's relative position within its industry.